From Microbiome to Microbiome: How Environmental Microbes Are - - PowerPoint PPT Presentation

from microbiome to microbiome how environmental microbes
SMART_READER_LITE
LIVE PREVIEW

From Microbiome to Microbiome: How Environmental Microbes Are - - PowerPoint PPT Presentation

October 11, 2019 From Microbiome to Microbiome: How Environmental Microbes Are Protecting Our Health Human Health and the Gut Microbiome Estimated 10 - 100 trillion microbial cells in the human gut microbiota Potentially exceeding the


slide-1
SLIDE 1

October 11, 2019

From Microbiome to Microbiome: How Environmental Microbes Are Protecting Our Health

slide-2
SLIDE 2

Human Health and the Gut Microbiome

  • Estimated 10 - 100 trillion microbial cells in

the human gut microbiota

  • Potentially exceeding the estimated 10 trillion

cells that comprise the human body

  • 3.3 million nonredundant microbial genes
  • 150x greater than the total number of genes

encoded in the human genome

slide-3
SLIDE 3

Relationship to health

The gut microbiota composition can be an indicator of:

  • BMI
  • blood glucose levels
  • cholesterol levels
  • cardiac health

Our microbiota is not only our first line of defense against disease but can also be used as an indicator of health status and disease susceptibility.

slide-4
SLIDE 4

Microbial Insights

  • Environmental Biotechnology laboratory
  • Founded in 1992 as a technology transfer
  • Specialize in molecular biological tools (MBTs)
  • >27 Years Experience
  • Accuracy & Precision
  • QAQC
  • Continuous Innovation
  • Dr. David C. White

University of Tennessee

slide-5
SLIDE 5

That’s why we care.

slide-6
SLIDE 6

Molecular Biological Analysis

slide-7
SLIDE 7

qPCR

Rapidly detect and quantify a target gene or microbial population

  • qPCR Amplification
  • Primers & probe bind to target gene
  • Fluorescence signal increase proportional to

concentration

  • Two main types of target genes
  • Taxonomic (16S rRNA gene)
  • Functional (e.g. Benzene carboxylase)
slide-8
SLIDE 8

CENSUS qPCR Approach

DHC Sample DNA Collection Extraction BVC VCR

slide-9
SLIDE 9

Petroleum Hydrocarbons

  • Numerous pathways – many are unknown

Toluene

Fuentes, S. et al. Appl Microbiol Biotechnol (2014) 98:4781.

slide-10
SLIDE 10
  • More research is needed to identify key players

Petroleum Hydrocarbons

Fuentes, S. et al. Appl Microbiol Biotechnol (2014) 98:4781.

slide-11
SLIDE 11

Effect of gut microbiome on toxins

  • Polyaromatic hydrocarbons converted to estrogenic metabolites in the colon:
  • Naphthalene
  • Phenanthrene
  • Pyrene
  • Benzo(a)pyrene
slide-12
SLIDE 12

Effect of gut microbiome on toxins

Sulfonation, methylation, oxidation, reduction: The microbiota dictates how a toxin in modulated within the gut

  • Different people, different microbiota,

different conversions of the toxin Bioavailability changes

  • Certain gut microbes can methylate mercury, making

it more toxic and easier to absorb

  • Some microbes can reduce the uptake of toxic

elements

slide-13
SLIDE 13

QuantArray Approach

TOD Sample DNA SubArray Collection Extraction Amplification RMO RDEG PHE NAH NAG PHN

slide-14
SLIDE 14

Microbial Insights Database – Adding Context

YOU ARE HERE

slide-15
SLIDE 15

Bio-Traps

  • 3-4 mm in diameter
  • 25% Nomex and 75% PAC
  • 74% porosity
  • 600 m2 of surface area/g
  • Heat sterilized at 270ºC
  • Colonized by native microbes
slide-16
SLIDE 16

Stable Isotope Probing (SIP)

slide-17
SLIDE 17

Stable Isotope Probing (SIP)

Residual 13C-Compound Local relative rate

13C/12C Dissolved Inorganic Carbon

Mineralization (C for energy)

13C/12C of Biomarkers

PLFA

Metabolism

DNA

(C for growth)

RNA

slide-18
SLIDE 18

Next Generation Sequencing

slide-19
SLIDE 19

Hierarchical Clustering - Biodiversity

slide-20
SLIDE 20

The effect of toxins on the gut microbiome

Changes in diversity matter

  • Cadmium, arsenic and lead
  • Gut microbial diversity significantly

changed

  • Herbicides in mice
  • Depression and anxiety symptoms that

correlate with changes in the gut microbiota

Human and Mouse Intestinal Microbiota

slide-21
SLIDE 21

Chlorinated Solvents

Stall? VC is more toxic!

Dehalococcoides mccartyi

Geobacter lovleyi, Dehalobacter, Sulfurospirillum, Desulfuromonas, Desulfitobacterium

Löffler et al. 2013, IJSEM, 63:625 He et al. 2003, Nature, 424:62

slide-22
SLIDE 22

(Parent compound) (Daughter product)

Compound Specific Isotope Analysis

Contaminant degradation = breaking bonds

slide-23
SLIDE 23

Isotope Fractionation

12C bonds tend to break more readily than 13C bonds. Throughout

degradation, 13C/ 12C ratio increases. VS

  • Proof of degradation
  • Degradation mechanism information
  • Source delineation
slide-24
SLIDE 24

The future of MBTs

slide-25
SLIDE 25

Data gaps – how can we do better?

  • qPCR and QuantArray provide quantitative data for microbes and gene

targets

  • What about activity?
  • NGS can provide a bigger picture of the overall microbiome
  • What about the health of the microbiome?
  • CSIA and SIP provide proof that a contaminant is being degraded
  • What about predicting future degradation trends?
slide-26
SLIDE 26

Metabolomics

slide-27
SLIDE 27

Metabolomics

Analysis of all small molecules (MW <1100) within an environmental sample

  • Identification of 80 – 100 known

compounds

  • Thousands of unknown compounds
  • Comparison of the overall metabolic

profile

  • Statistical Analysis and pattern

recognition

  • Predictive capabilities
  • Activity of key degraders
slide-28
SLIDE 28

SBIR Metabolomics Study

RT: 0.00 - 25.02 2 4 6 8 10 12 14 16 18 20 22 24 Time (min) 18.37 18.21 11.66 18.46 12.19 11.03 17.68 13.78 18.81 10.28 16.75 0.91 6.01 18.94 16.35 19.71 8.37 9.32 14.15 6.43 1.25 19.91 15.11 5.58 5.36 20.30 21.56 22.28 4.35 2.69 100 90 80 70 60 50 40 30 20 10

slide-29
SLIDE 29

SBIR Metabolomics Study

C

  • m

p

  • n

e n t Y ( 8 . 4 % ) C

  • m

p

  • n

e n t X ( 9 . 9 % ) Component Z (7%)

Inactive cis-DCE Active Slowing?

ti t0 t1 t2 t3 t4 tx t5

Component Z (6.6%) C

  • m

p

  • n

e n t Y ( 1 . 3 % ) C

  • m

p

  • n

e n t X ( 7 . 7 % )

Inactive & Startup Active Active

ti t0 t1 t2 t3 t4 t5

Vinyl chloride

slide-30
SLIDE 30
slide-31
SLIDE 31

Where is bioremediation headed?

Th The f future re o

  • f

f bio biore remedia iatio ion? n? PL PLFA qP qPCR R SI SIP CS CSIA A Gen Genomics s Me Metabolomics P r P r

  • t
  • t

e e

  • m
  • m

i i c s c s

slide-32
SLIDE 32

Thank you for your time

Are there any questions?